Skip to main content

Table 3 Number and nature of cores included in the Test- and Validation-TMA series after central pathology review

From: The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation

Sites

Number of Patients

Number of Tumor Cores per Patient

Number of Benign Adjacent Cores per Patient

0

1

2

3

> 4

0

1

2

3

> 4

CHUM

304

2

6

55

236

5

1

16

241

37

9

CHUdeQ-UL

301

1

9

65

98

128

4

130

104

36

27

MUHC

304

6

26

93

167

12

5

50

208

37

4

UHN

303

9

10

111

119

54

1

37

177

28

60

VPC

300

5

9

58

165

63

5

51

162

49

33

Total

1512

23

60

382

785

262

16

284

892

187

133